NO921910L - 14alfa,17alfa-overbroede-oestratriener - Google Patents

14alfa,17alfa-overbroede-oestratriener

Info

Publication number
NO921910L
NO921910L NO92921910A NO921910A NO921910L NO 921910 L NO921910 L NO 921910L NO 92921910 A NO92921910 A NO 92921910A NO 921910 A NO921910 A NO 921910A NO 921910 L NO921910 L NO 921910L
Authority
NO
Norway
Prior art keywords
17alpha
14alpha
oestratriene
16alpha
17beta
Prior art date
Application number
NO92921910A
Other languages
English (en)
Other versions
NO921910D0 (no
NO301232B1 (no
Inventor
Gerald Kirsch
Guenter Neef
Henry Laurent
Rudolf Wiechert
James R Bull
Peter Esperling
Walter Elger
Sybille Beier
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3939893A external-priority patent/DE3939893A1/de
Priority claimed from DE3939894A external-priority patent/DE3939894A1/de
Priority claimed from DE4033871A external-priority patent/DE4033871A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO921910L publication Critical patent/NO921910L/no
Publication of NO921910D0 publication Critical patent/NO921910D0/no
Publication of NO301232B1 publication Critical patent/NO301232B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Medicinal Preparation (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Fats And Perfumes (AREA)
NO921910A 1989-11-29 1992-05-14 Analogifremgangsmåte for fremstilling av terapeutisk aktive 14<alfa>,17<alfa>-overbroede östratriener NO301232B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3939893A DE3939893A1 (de) 1989-11-29 1989-11-29 14(alpha),17(alpha)-etha(e)no-16ss-hydroxy-estratriene
DE3939894A DE3939894A1 (de) 1989-11-29 1989-11-29 14(alpha),17(alpha)-ethano-16(alpha)-hydroxy-estratriene
DE4033871A DE4033871A1 (de) 1990-10-22 1990-10-22 Verfahren zur herstellung von 14(alpha), 17(alpha)-etheno- und ethano-estriolen
PCT/DE1990/000924 WO1991008219A1 (de) 1989-11-29 1990-11-29 14α,17α-ÜBERBRÜCKTE 16-HYDROXYESTRATRIENE

Publications (3)

Publication Number Publication Date
NO921910L true NO921910L (no) 1992-05-14
NO921910D0 NO921910D0 (no) 1992-05-14
NO301232B1 NO301232B1 (no) 1997-09-29

Family

ID=27200525

Family Applications (1)

Application Number Title Priority Date Filing Date
NO921910A NO301232B1 (no) 1989-11-29 1992-05-14 Analogifremgangsmåte for fremstilling av terapeutisk aktive 14<alfa>,17<alfa>-overbroede östratriener

Country Status (21)

Country Link
US (1) US5529993A (no)
EP (1) EP0430386B1 (no)
JP (1) JP2996723B2 (no)
KR (1) KR100203003B1 (no)
CN (2) CN1031061C (no)
AT (1) ATE122053T1 (no)
AU (1) AU649239B2 (no)
CA (1) CA2069880A1 (no)
CZ (1) CZ286259B6 (no)
DE (1) DE59009011D1 (no)
DK (1) DK0430386T3 (no)
ES (1) ES2074531T3 (no)
FI (1) FI102902B1 (no)
HU (1) HU220217B (no)
IE (1) IE67321B1 (no)
IL (1) IL96501A (no)
NO (1) NO301232B1 (no)
PH (1) PH31668A (no)
PT (1) PT96035B (no)
RU (1) RU2087479C1 (no)
WO (1) WO1991008219A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4132182A1 (de) * 1991-09-24 1993-03-25 Schering Ag 11(beta)-substituierte 14, 17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
DE4222316A1 (de) * 1992-07-03 1994-01-05 Schering Ag Verfahren zur Herstellung von Etheno- und Ethano-16â,17µ-Steroiddiolen und deren Derivaten
DE4429397C2 (de) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE4429398C2 (de) * 1994-08-09 1997-09-11 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
CN113999276B (zh) * 2020-07-28 2023-08-15 威智医药股份有限公司 一种去乙酰毛花苷中间体的提纯方法以及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE808679C (de) * 1948-10-19 1951-07-19 Hansen Neuerburg & Co Mit Leitflaechen versehene Propelleranordnung fuer Schiffe
DE3628189A1 (de) * 1986-08-20 1988-02-25 Schering Ag Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
DE3808679A1 (de) * 1988-03-11 1989-09-21 Schering Ag Verfahren zur herstellung von 14,17(alpha)-etheno-1,3,5(10)-estratrienen

Also Published As

Publication number Publication date
PT96035B (pt) 1998-01-30
PT96035A (pt) 1991-09-13
CZ594390A3 (cs) 1999-11-17
AU6884191A (en) 1991-06-26
DE59009011D1 (de) 1995-06-08
CN1057769C (zh) 2000-10-25
US5529993A (en) 1996-06-25
JPH05503080A (ja) 1993-05-27
CN1117050A (zh) 1996-02-21
DK0430386T3 (da) 1995-09-04
ES2074531T3 (es) 1995-09-16
HU220217B (hu) 2001-11-28
CN1031061C (zh) 1996-02-21
EP0430386A1 (de) 1991-06-05
IE67321B1 (en) 1996-03-20
ATE122053T1 (de) 1995-05-15
CA2069880A1 (en) 1991-05-30
HUT67420A (en) 1995-04-28
FI102902B (fi) 1999-03-15
HU9201805D0 (en) 1992-08-28
IE904316A1 (en) 1991-06-05
IL96501A (en) 1997-07-13
PH31668A (en) 1999-01-18
IL96501A0 (en) 1991-08-16
AU649239B2 (en) 1994-05-19
WO1991008219A1 (de) 1991-06-13
FI920843A0 (fi) 1992-02-26
CN1052677A (zh) 1991-07-03
KR100203003B1 (ko) 1999-06-15
NO921910D0 (no) 1992-05-14
KR927003620A (ko) 1992-12-18
RU2087479C1 (ru) 1997-08-20
FI102902B1 (fi) 1999-03-15
JP2996723B2 (ja) 2000-01-11
NO301232B1 (no) 1997-09-29
EP0430386B1 (de) 1995-05-03
CZ286259B6 (cs) 2000-02-16

Similar Documents

Publication Publication Date Title
ZA918570B (en) Azasteroid compounds for the treatment of prostatic hypertrophy,their preparation and use
EA200100108A1 (ru) Применение биогенных сульфаматов эстрогенов для гормонзаместительной терапии
DE3782468D1 (de) Verfahren zur behandlung von maennlicher sexueller dysfunktion.
ES8502709A1 (es) Procedimiento para la preparacion de 1-alquil-androsta-1,4-dien-3,17-dionas
KR950702120A (ko) 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis)
ATE122053T1 (de) 14alpha, 17alpha-überbrückte 16- hydroxyestratriene.
ATE175418T1 (de) 15,15-dialkylsubstituierte östradiolderivate
SE7705213L (sv) Antikonceptionellt medel
ES8704897A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas
MX9804290A (es) Derivados de aminoalcohol, metodos para su produccion y medicamentos que los contienen.
JPS5421509A (en) Drive stop system for motor
NZ334634A (en) Use of a protein extracted from mammalian liver for treating HIV
ES2109136A1 (es) Polimeros biodegradables de esqueleto carbonado de acetales de centeno y alcoholes, procedimiento para su obtencion y composicion y utilizacion correspondientes.
CA2238710A1 (en) New amino alcohol derivatives, processes for their production and pharmaceutical agents containing these compounds
UA66809C2 (uk) Спосіб лікування гіперглікемії похідною тіазолідиндіону
UA5533A1 (uk) Спосіб одержання ін&#39;єкційної форми дисульфіраму
JPS51118219A (en) Hydraulic lock device